Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase...
Leadership
Douglas E. Love Esq., J.D.
CEO, President & Director
Jennifer Lew CPA
Executive VP, CFO & Corporate Secretary
Ted Yednock Ph.D.
Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board
Dean R. Artis Ph.D.
Chief Scientific Officer & Executive VP
Michael Overdorf M.B.A.
Executive VP & Chief Business Officer
Henk-Andre Kroon M.D.
Senior Vice President of Translational Medicine
Jamie Dananberg M.D.
Executive VP & Chief Medical Officer
Shikhar Agarwal M.B.A.
Senior VP & Head of Commercial
Sunil Mehta Pharm.D.
Senior VP of Medical Affairs
Lloyd Clark M.D.
Senior Vice President of Ophthalmology Strategy & Innovation
